0:03:08 Myeloma 101
Dr. Brian G.M. Durie
0:30:05 Side Effects & Symptom Management
Ann McNeill, RN, MSN, APN
1:05:45 Diagnosis, Monitoring & Early Disease Management
Dr. Brian G.M. Durie
1:42:17 Latest Advances in Immune Therapies: A Focus on CAR T-cell Therapies
Dr. Yi Lin
2:13:29 Approaches to Relapsed Myeloma: What Are the Current Bispecifics & Novel Agents?
Dr. Nikhil Munshi
Dr. Durie kicks off the webinar with a review of Myeloma 101. He will discuss MGUS, smoldering myeloma, and active myeloma, and address when patients may consider beginning treatment. He will also cover tests for diagnosis and monitoring, as well as how the disease is staged, and more.
Next, IMF Nurse Leadership Board Member Ann McNeill RN, MSN, APN (The John Theurer Cancer Center, Hackensack Meridian Hospital — Hackensack, NJ) will discuss Side Effects and Symptom Management — how patients can best manage myeloma-related symptoms and side effects along with side effects brought on by treatment. She will also outline the most common side effects for each myeloma drug category, and more.
In his segment, Diagnosis, Monitoring & Early Disease Management, Dr. Durie will discuss if screening for monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) can become a new standard of care and how early intervention for high-risk smoldering multiple myeloma (HR SMM) can lead to best outcomes, even a cure.
A panel discussion will follow this session before the short break.
In this presentation on the Latest Advances in Immune Therapies: A Focus on CAR T-cell Therapies, Dr. Yi Lin will discuss the recent FDA approval of the new CAR T product from Janssen CARVYKTI which, along with previously approved ABECMA [BMS] provide a huge opportunity for patients to achieve excellent outcomes in the relapsed/refractory multiple myeloma (RRMM) setting.
In the next segment, Dr. Nikhil Munshi will discuss Approaches to Relapsed Myeloma: What Are the Current Bispecifics & Novel Agents? where the whole range of emerging therapies will be discussed, including the very exciting new CelMods.
Download Slides: [ Ссылка ]
_______________
Improving Lives | Finding the Cure
In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: [ Ссылка ]
Visit our website at: [ Ссылка ]
Find us online:
Facebook: @myeloma | [ Ссылка ]
Twitter: @IMFMyeloma | [ Ссылка ]
Instagram: @imfmyeloma | [ Ссылка ]
LinkedIn: [ Ссылка ]
Support the IMF! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
